Licensed Practical Nurse in Annapolis, MD Accepting Medicare
3 Licensed Practical Nurse nurses found. Showing 1 - 3
 Diana Abell, LPN, IBCLC Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Suite G50, Annapolis, MD 21401 Phone: 443-481-4400 Fax: 410-573-1097 |
Mrs. Ada Iola Anderson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Harry S Truman Pkwy, Suite 231, Ms 3103, Annapolis, MD 21401 Phone: 410-222-7108 Fax: 410-222-7231 |
Mrs. Sheila Robin Leone, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 931 Blue Ridge Dr, Annapolis, MD 21409 Phone: 410-222-1689 |
News Archive
Parents share arduous, circuitous journey to get referrals for childhood epilepsy surgery
Having a child diagnosed with epilepsy can be a frightening and confusing time. Now, parents share their arduous and "circuitous" journey to get referrals for pediatric epilepsy surgery once their child's disease stops responding to anti-seizure medications. The UCLA study sheds light on the difficulties parents face obtaining specialty and sub-specialty care for their children during an already stressful time.
Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement
Merge Healthcare, a leading provider of healthcare enterprise imaging and interoperability solutions, and Ophthalmic Imaging Systems, a leading provider of digital imaging and informatics solutions for ophthalmology and other medical specialties, today announced the signing of a definitive merger agreement pursuant to which Merge Healthcare will acquire OIS.
Novogen partners with Genea Biocells to accelerate testing for neurodegenerative diseases
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
Dyadic signs non-binding term sheet with EnGen Bio for potential outlicense of C1 platform technology
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
MU's program provides solutions for states with physician shortage
An innovative program at the University of Missouri School of Medicine could help states deal with a dilemma in Washington, D.C. If deficit-reduction measures cut billions of dollars for training physicians who are already in short supply, who will care for the more than 30 million newly insured patients entering the health care system?
› Verified 1 days ago